ChanceR. E.RootM. A.GallowayJ. A. (1975). The immunogenicity of insulin preparations. Acta Endocrinologica (Kbh.), Suppl. 205, 185
2.
ChristiansenA. H. (1970) New method for determination of insulin-binding immunoglobulins in insulin-treated diabetic patients. Hormone and Metabolic Research, 2, 187
3.
DaggettP.MustaffaB. R.NabarroJ. D. N. (1977). Effects of highly purified insulin on dosage requirements. Practitioner, 218, 563
KerpL.KasemirH. (1975). High and low affinity insulin antibodies. Acta Endocrinologica (Kbh.) Suppl.205, 211
8.
KuhnauJ.Jr.StrizkyV., A. (1963). Mit Schweineinsulin erfolgreich behandelte Insulinresistenz bei Diabetes Mellius. Schweiz, med. Wschr., 93, 914
9.
LavauxJ. P.OomsH. A.ChristiansenA. H. (1974). Edited by BastenieP. A.GeptsW.. Immunity and auto-immunity in diabetes mellitus. Excerpta Medica (Amsterdam). International Congress Series, 316, 40
10.
OakleyN. W. (1976). Effect of ‘fractionated’ insulins on total plasma insulin binding capacity and insulin requirements in severe diabetes. Lancet, 1, 994
11.
SchlictkrullJ. (1974). Monocomponent insulin and its clinical implications. Immunity and auto-immunity in diabetes mellitus. Excerpta Medica (Amsterdam). International Congress Series, 316, 29
12.
Symonides-LaweckaA.LudwiczakH.RogalaH.LaweckiJ.CzyzykA. (1974). Insulin-binding antibodies in serum of diabetic children treated with mono-component insulin. Acta diabetologica latina, 2, 165
13.
TantilloJ. J.KaramI. H.BurrilK. C.JonesM. A.GrodskyG. M.ForshamP. H. (1973). Antigenicity of ‘single-peak’ insulin preparations in diabetics. Diabetes, 22 (Suppl. 1), 293
14.
YueD. R.TurtleJ. R. (1977). New forms of insulin and their use in the treatment of diabetes. Diabetes, 26, 341